Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Episode Summary

Introduction

Dr. Auric Bishop (also known as Warwick Bishop), a cardiologist, author, and CEO of the Healthy Heart Network, hosts this episode focused on managing elevated triglycerides. The episode is part two of a triglyceride series, diving into both lifestyle interventions and medical approaches to lowering triglycerides, which affect millions of Australians and contribute to preventable heart disease.

Key Takeaways:

• Elevated triglycerides are markers of underlying metabolic dysfunction including insulin resistance, central weight gain, visceral fat, inflammation, and high blood pressure—creating a "nasty pack" of cardiovascular risk factors.

• Lifestyle management of triglycerides should be the first step and includes reducing saturated fats and refined sugars in the diet, since both can be converted to fatty acids and triglycerides.

• Exercise lowers triglycerides through two mechanisms: by improving insulin resistance and directly using triglycerides as fuel when energy expenditure increases.

• Alcohol significantly elevates triglycerides through enzymatic pathways that convert it to acetyl-CoA, a building block for fatty acid production, making alcohol reduction critical.

• The landmark GISSI-P trial demonstrated that one gram of fish oil daily reduced sudden cardiac death by 45% and overall mortality by 20% in post-heart attack patients, suggesting marine omega-3s are most beneficial for secondary prevention.

• Subsequent large trials (VITAL, ASCEND, ORIGIN) showed limited benefit of fish oil supplementation in primary prevention populations without prior cardiac events, indicating timing and patient selection are crucial.

• The REDUCE-IT trial demonstrated that icosapent ethyl (a pure EPA supplement) reduced major adverse cardiac events by approximately 20% in high-risk patients on statin therapy, suggesting the benefit may relate to anti-inflammatory effects rather than triglyceride reduction alone.

• The Physician's Health Study found that individuals in the highest quartile of omega-3 blood levels had a 90% relative risk reduction in cardiovascular events, with omega-3 index being a stronger predictor of sudden cardiac death than cholesterol or inflammation levels.

• EPA appears particularly cardioprotective, while DHA is more important for fetal brain and eye development, suggesting different roles for the two marine omega-3 fatty acids.